Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Journal of Medicinal Chemistry - United States
doi 10.1021/acs.jmedchem.8b01218
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2018
Authors
Publisher
American Chemical Society (ACS)